Ibrutinib in relapsed hairy cell leukemia variant: A case report and review of the literature-Reference-Cited by-同舟云学术

Ibrutinib in relapsed hairy cell leukemia variant: A case report and review of the literature

Published:2020-10-11 Issue:5 Volume:38 Page:823-826
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Visentin Andrea¹²^ORCID,Imbergamo Silvia¹,Trimarco Valentina¹,Pravato Stefano¹,Romano Gargarella Leila¹,Frezzato Federica¹²,Scapinello Greta¹,Bertorelle Roberta³,Piva Elisa⁴,Facco Monica¹²,Semenzato Gianpietro¹²,Piazza Francesco¹²^ORCID,Trentin Livio¹²

Affiliation:

1. Hematology and Clinical Immunology Unit Department of Medicine University of Padua Padua Italy

2. Venetian Institute of Molecular Medicine Centro di Eccellenza per la Ricerca Biomedica Avanzata Padua Italy

3. Immunology and Molecular Diagnostic Oncology Unit Veneto Institute of Oncology IOV‐IRCSS Padua Italy

4. Laboratory Medicine Unit Department of Medicine University of Padua Padua Italy

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2810

Reference10 articles.

1. Hairy cell leukemia: present and future directions

2. The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma

3. Bendamustine and Rituximab in Relapsed and Refractory Hairy Cell Leukemia

4. Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: a report of three cases

5. Distinguishing hairy cell leukemia variant from hairy cell leukemia: Development and validation of diagnostic criteria

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hairy cell leukemia 2024: Update on diagnosis, risk‐stratification, and treatment—Annual updates in hematological malignancies;American Journal of Hematology;2024-03-05

2. Untangling hairy cell leukaemia (HCL) variant and other HCL‐like disorders: Diagnosis and treatment;Journal of Cellular and Molecular Medicine;2023-12-14

3. A Case of Hairy Cell Leukemia Variant: Literature Analysis With Focus on Unmet Needs;Cureus;2023-10-15

4. Refractory and relapsed hairy-cell leukemia (HCL): casting light on promising experimental drugs in clinical trials;Expert Opinion on Investigational Drugs;2023-03-23

5. Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders;Frontiers in Oncology;2022-12-22